Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Annals of the Royal College of Surgeons of England|May 4, 2016
The impact of neoadjuvant chemotherapy on cardiopulmonary physical fitness in gastro-oesophageal adenocarcinomaRcf Sinclair, M Navidi, S M Griffin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 20, 2003
Oxaliplatin and capecitabine chemotherapy for advanced colorectal cancer: a single institution's experienceK Sumpter, C Harper-Wynne, D Cunningham, et al.
Leukemia & Lymphoma|December 28, 1999
Oral idarubicin as a single agent therapy in patients with relapsed or resistant multiple myelomaK Sumpter, R L Powles, N Raje, et al.
The British Journal of Surgery|March 31, 2018
Cardiopulmonary fitness before and after neoadjuvant chemotherapy in patients with oesophagogastric cancerM Navidi, A W Phillips, S M Griffin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2010
Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II studyS Rao, N Starling, D Cunningham, et al.
British Journal of Cancer|June 2, 2005
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECFK Sumpter, C Harper-Wynne, D Cunningham, et al.
British Journal of Cancer|April 3, 2003
Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancerI Chau, M Allen, D Cunningham, et al.
The British Journal of Surgery|October 4, 2016
Prognostic impact of extracapsular lymph node involvement after neoadjuvant therapy and oesophagectomyS M Lagarde, M Navidi, S S Gisbertz, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 15, 2016
Sorafenib for the Treatment of Advanced Hepatocellular Cancer - a UK AuditJ King, D H Palmer, P Johnson, et al.
Pageof 1